Literature DB >> 25970735

Reply: To PMID 25086190.

W Asher Wolf1, Evan S Dellon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25970735      PMCID： PMC4772738          DOI： 10.1016/j.cgh.2015.05.008

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  5 in total

1.  Therapeutic end points in eosinophilic esophagitis: is elimination of esophageal eosinophils enough?

Authors:  Ikuo Hirano
Journal:  Clin Gastroenterol Hepatol       Date:  2012-02-22       Impact factor: 11.382

Review 2.  Advances in clinical management of eosinophilic esophagitis.

Authors:  Evan S Dellon; Chris A Liacouras
Journal:  Gastroenterology       Date:  2014-08-07       Impact factor: 22.682

3.  Development and field testing of a novel patient-reported outcome measure of dysphagia in patients with eosinophilic esophagitis.

Authors:  E S Dellon; A-M Irani; M R Hill; I Hirano
Journal:  Aliment Pharmacol Ther       Date:  2013-07-09       Impact factor: 8.171

4.  Predictors of response to steroid therapy for eosinophilic esophagitis and treatment of steroid-refractory patients.

Authors:  W Asher Wolf; Cary C Cotton; Daniel J Green; Julia T Hughes; John T Woosley; Nicholas J Shaheen; Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-30       Impact factor: 11.382

5.  Development and validation of a symptom-based activity index for adults with eosinophilic esophagitis.

Authors:  Alain M Schoepfer; Alex Straumann; Radoslaw Panczak; Michael Coslovsky; Claudia E Kuehni; Elisabeth Maurer; Nadine A Haas; Yvonne Romero; Ikuo Hirano; Jeffrey A Alexander; Nirmala Gonsalves; Glenn T Furuta; Evan S Dellon; John Leung; Margaret H Collins; Christian Bussmann; Peter Netzer; Sandeep K Gupta; Seema S Aceves; Mirna Chehade; Fouad J Moawad; Felicity T Enders; Kathleen J Yost; Tiffany H Taft; Emily Kern; Marcel Zwahlen; Ekaterina Safroneeva
Journal:  Gastroenterology       Date:  2014-08-23       Impact factor: 22.682
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.